Why Novavax Stock Blasted 8% Higher Today
There's nothing like a surge in a deadly disease to encourage investors back into a noted healthcare stock. This dynamic benefited biotech (NASDAQ: NVAX) on Thursday.
It was also on the back of one pundit's recommendation upgrade; together these factors sent the company's share price 8% skyward. That performance trounced that of the S 500 index, which essentially traded sideways.
The latest COVID subvariant, Eris, is beginning to get significant coverage in the media. For instance, on the website of the TV news magazine Today, Eris was described as "sweeping" through this country.
Source Fool.com
Novavax Inc. Stock
€13.05
-0.520%
Our community is currently high on Novavax Inc. with 5 Buy predictions and 1 Sell predictions.
With a target price of 17 € there is a positive potential of 30.27% for Novavax Inc. compared to the current price of 13.05 €.
